Clinical Studies for PTLD Cancer

The goals of the PTLD Cancer clinical studies are to evaluate whether this investigational treatment works and whether it is safe for patients with post-transplant lymphoproliferative disease (PTLD). PTLD is a type of cancer or lymphoma that may occur after bone marrow or organ transplant.  It may occur due to the Epstein Barr Virus when the immune system is suppressed.

Phase 3 clinical studies of an investigational treatment are currently enrolling patients with EBV-related PTLD cancer. These are single arm open-label studies, which means every participant will receive the investigational treatment since the study is not designed with a placebo.

These studies are currently enrolling patients of any age who have the following select criteria:

  • had a bone marrow or organ transplant

  • been diagnosed with EBV-related PTLD, which is a type of cancer or lymphoma, after their transplant

TALK TO AN Atara representative about PTLD CANCER

Find out more about PTLD cancer and an investigational treatment option by clicking here to contact an Atara representative.